-
Signature
-
/s/ Nick Pizzie, Attorney-in-Fact
-
Issuer symbol
-
AXSM
-
Transactions as of
-
22 Aug 2025
-
Transactions value $
-
-$4,405,216
-
Form type
-
4
-
Filing time
-
26 Aug 2025, 19:00:03 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| JEFFS ROGER |
Director |
C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK |
/s/ Nick Pizzie, Attorney-in-Fact |
26 Aug 2025 |
0001231615 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AXSM |
Common Stock |
Sale |
-$2M |
-16.7K |
-9.96% |
$120.08 |
151K |
22 Aug 2025 |
Direct |
F1, F2, F3 |
| transaction |
AXSM |
Common Stock |
Sale |
-$2.4M |
-20K |
-13.25% |
$120.03 |
131K |
26 Aug 2025 |
Direct |
F1, F2, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: